Panel prep · 21 September 2026 · Bremen

Sixteen pitches.
Three questions
each.

Constructor Start Demo Day #4 puts sixteen finalists on stage. Half of them are real deep tech — photonic memory, quantum models, beamed-power rockets, a cancer molecule. This sheet is written for an investor who is not a physicist and does not want to pretend to be one. Every summary says what the company sells and what is actually proven today; every question is in plain English, can be answered in a minute, and does not need a lab to judge the answer.

Startups
16
Selected from
2,100+ applications
Prize
$100K for equity
Follow-on
up to $1M via fund & angels
Deep tech
9 of 16

How to use this. Q1 is the one to ask if you get a single question — it is the question whose answer most changes whether the company is investable. Q2 and Q3 are held in reserve. Where the technology is hard to judge from the stage, the question deliberately moves to something you can judge: who pays, what is signed, what would fail, who decides. A founder cannot bluff a customer name or a contract value the way they can bluff physics. Prepared 21 Sep 2026 · sources: company sites and the pitch decks published on the Demo Day page · deck facts marked “deck”

CauseNex

Predictive maintenance · Bremen · Ideation

A sensor box plus software that watches rotating machines — motors, pumps, gearboxes, CNC spindles — and warns before they break. The difference they claim is causal: instead of saying “this vibration looks unusual”, the system says which physical fault is causing it (for example, shaft misalignment driving bearing resonance) and when it will fail. Target buyer is the German industrial Mittelstand. The company comes out of Constructor University Bremen research.

Their own site says the product is in development and not available to buy. The numbers on the page are market numbers, not customer results: 73% of bearing failures give no warning signal, ~€18,000 average cost of an unplanned failure at a German SME plant, ~9 hours of downtime per failure. Software MVP is described as ready, hardware is not. causenex.com, retrieved 21 Sep 2026 · earliest stage of the sixteen

Lead with this

First customer

Predictive maintenance is a crowded market, and most factories already have someone selling them vibration sensors. Do you have a factory today that has let you put your hardware on a real machine — paid or unpaid — and what did the machine do that you predicted?

You are testing whether “ideation stage” means “no hardware yet” or “no customer yet”. Those are very different risks. A named plant and one caught failure is the whole answer.

If there is time

Why they switch

Imagine a plant manager who already gets alerts from an existing system. In his own words, what does he get from you that he did not have before, and how soon does he see it?

Hardware or software

You sell both a sensor and an AI. Which one is the business in five years, and which one would you happily give away to win the other?

Cytokyn M

Biotech · Germany · Preclinical

A redesigned version of an existing, approved medicine. The drug class — an IL-1 receptor antagonist — already exists as Kineret/anakinra, which works but has a very short half-life (about 4 hours), needs a daily injection and a cold chain. Cytokyn M’s molecule, CIRPELIRA, is the same protein rebuilt in a different order so that it is physically more stable, which should mean fewer injections. The targets are Long COVID first and then “inflammaging” — chronic inflammation in people over 50.

From the deck: raising €2.5M pre-seed to finish preclinical work, file with the EMA and be ready for a first-in-human trial; Phase 1 planned to start 2027, Phase 2 in 2028. Semifinalist in the XPRIZE Healthspan competition. Co-founder Prof. Dr. Dr. Michael Wiechmann comes from Sandoz. The comparison table against Kineret is marked as in silico (computer), in vitro and bacterial-cell work — the advantage claims are modelling and bench data, not animals or patients yet. Cytokyn M pitch deck, slides 8–23 · deck read 21 Sep 2026

Lead with this

Evidence today

I am not a biologist, so help me place this. Everything I can see comparing your molecule to Kineret is computer modelling and test-tube work. What has been tested in a living animal so far, and what exactly will the €2.5M prove that is not proven now?

The honest answer is probably “animal work is what the round pays for”. That is fine — you just need to hear it said plainly, because it sets the risk and the next milestone.

If there is time

Who pays

The old drug is off-patent and cheap. If yours is better but new, who pays for it — and what yearly price per patient do your plans assume?

Proving it works

Long COVID is famous for failed trials, partly because patients are so different. Which patients would you choose for the first trial, and what result would a regulator accept as success?

DealBooster

Sales enablement AI · California · Scaling

A “flight simulator” for salespeople: AI plays the customer, the rep practises the conversation, and the system scores things that show up in the P&L — attach rates, objection handling, upsell, margin. It also benchmarks reps and teams against each other, which is what a sales director actually buys. Main markets are retail chains, dealerships, pharma reps and telco.

The one real proof point on the site is a pilot with iSpace, an Apple Premium Partner inside the ASBIS group: +20% revenue per rep, +21% gross profit, 146% ROI, and ASBIS then committing to roll it out across the iSpace network in March 2026. Everything else — the “$237 basket gap”, “$120K enterprise deal gap” — is illustration, not customer data. No pricing is published. dealbooster.ai, retrieved 21 Sep 2026 · deck is image-only, no extractable text

Lead with this

The one number

The iSpace result is the strongest thing in your pitch, so I want to understand it. Was there a control group of reps who did not use DealBooster in the same weeks — and how do you separate your effect from a new promotion, a new phone launch or a good season?

If there was a control group, this is a serious company. If there was not, the number is a story, and the follow-up is simply: what are you measuring in the rollout so the next number is defensible?

If there is time

Pilot to contract

How much revenue is under signed contract today, as opposed to in pilots — and how many months does it take you to get from pilot to a paid rollout?

Year two

Practice-with-AI tools are easy to launch and easy to cancel. What makes a retailer renew in year two, when the novelty is gone?

Explaino

Enterprise knowledge AI · Germany · Scaling

Turns company knowledge into training material automatically. You upload a document, paste text or record your screen; the AI reads it, builds a structure, and produces a learning-optimised video with quizzes, either in Explaino’s own LMS or exported to the customer’s (SCORM). The pitch is onboarding, software rollouts and the knowledge that leaves when an employee leaves. Everything is hosted in the EU, with GDPR, ISO 27001 and DORA compliance pushed to the front — which is the real selling point for German banks and insurers.

Named results come from two big regulated German institutions: a VP at Sparkasse citing 7× higher knowledge retention, and an IT solution designer at AOK citing 85% faster content creation. The site’s ROI calculator will happily show “€1,039,980 annual savings” for a large headcount — that is a model, not a measured customer result. explaino.ai, retrieved 21 Sep 2026 · deck is image-only, no extractable text

Lead with this

Paid or pilot

Sparkasse and AOK are exactly the logos that make a German software company. Are those paid annual contracts or pilots — and what is your recurring revenue today?

Large regulated customers take a year to buy and then stay for a decade, so a signed Sparkasse contract is worth more than most metrics. A quoted VP with no contract is worth much less.

If there is time

Measuring the claim

“Seven times higher retention” is a strong claim. How was that measured, by whom, and over how long?

The platform risk

Microsoft and the big LMS vendors are adding “turn this document into a course” buttons. In two years, what do you have that they do not?

FerroptoCure

Oncology · Japan / Australia · Phase 1 running

An oral cancer drug that attacks the defence system tumours use to survive chemotherapy. Cancer cells protect themselves from oxidative damage; FerroptoCure’s compound FC-004 blocks two of those defences at once (xCT and ALDH), which pushes the cell into ferroptosis — an iron-dependent form of cell death. First indication is triple-negative breast cancer, where survival is poor and resistance is common. The science comes out of ~15 years of work at Keio University.

This is the most advanced company on the list. From the deck: $12.5M already raised in equity plus Japanese AMED grants, a collaboration with MD Anderson, three patents, 85% tumour reduction in mouse models, and — the key fact — a first-in-human Phase 1a/b trial already running in Japan (registry number jRCT2031230531, National Cancer Center), with “favourable safety profile observed” so far. Plan: Phase 1 in Australia 2027, Phase 2 in US/EU 2029, licensing to pharma along the way. FerroptoCure deck slides 6–11 · deck read 21 Sep 2026

Lead with this

Read-out

You are already dosing patients, which puts you ahead of everyone else in this room. What have you seen in those patients so far beyond safety, and when do you get the data that tells you whether it is working?

In biotech the whole valuation sits on the next data point and its date. If the answer is vague about timing, that is the finding.

If there is time

The exit

Your plan is to license to a pharma company rather than sell the drug yourself. What exactly must you show before a partner signs — and have those conversations started?

Money to the milestone

Most of the $12.5M so far is grants. How much more cash do you need to reach Phase 2, and what is the plan if grant money is not repeated?

Hi Holo

AI engine · Georgia · PMF claimed

An engine that does the parts of an AI system which must be exact. The pitch: today’s models guess, cost a fortune in GPUs and cannot explain themselves, which will collide with the EU AI Act. Holo Engine is presented as the opposite — same input always gives the same output, runs on a normal CPU in about 10 MB, learns from six to eight examples, and returns an audit trail. In practice it is sold as a tool the LLM calls: the model handles language, the engine handles routing, retrieval, verification and state.

Raising $3M at $30M post-money (10%), 18-month plan, 1–3 strategic investors. Benchmarks are self-run: 90% Recall@3 without embeddings, 33× faster than PySCF on a quantum-chemistry basis set, 13–39× on exact solving versus SymPy. The technical story rests on hyperbolic p-adic trees and energy minimisation, and is credited to a single inventor, Kirill Kazakov, with a physics/maths advisor. No customer is named anywhere, although the stage is given as product-market fit. Hi Holo deck + hiholo.ai · read 21 Sep 2026

Lead with this

Who pays

I cannot judge the mathematics from the stage and I will not pretend to. So let me ask the part I can judge: you describe the stage as product-market fit — who is paying you today, how much, and for which job that they used to do another way?

“Product-market fit” with no named customer is the single biggest gap in this pitch. One paying logo changes the whole conversation; a list of benchmarks does not.

If there is time

Independent test

All the benchmarks are yours. Would you run a test that the customer designs, on their data, with someone neutral watching — and what would you expect it to show?

Key-person risk

The engine was invented by one person. What happens to the company if he steps away, and who else can develop the core today?

Litero

EdTech · United States · ~$1M ARR

A writing workspace built for students instead of a general chatbot. It finds real academic sources, helps build an outline, keeps the student writing rather than pasting, and adds the tools students actually worry about: citation formatting, plagiarism check, AI detection, a predicted grade and a tutor that quizzes them. The positioning is deliberately about academic safety — 70%+ of students say they are afraid to use ChatGPT for coursework.

The only company here with a clean commercial picture: $780K pre-seed raised in May 2025 from six VCs and angels, on track for $1M ARR by March 2026, gross margin improved to 83% by optimising API cost, free-user base up 10× in a year, and now raising $1.5M for distribution. Price is around $30/month, or $7.90/month billed annually. In their own survey 45% of subscribers prefer Litero to ChatGPT, 19% prefer ChatGPT, 37% cannot compare. Litero deck + litero.ai · read 21 Sep 2026

Lead with this

Retention

Students are the hardest subscribers in software: they churn after the deadline and disappear all summer. What share of your paying users are still paying six months later, and what does one student pay you over their whole time with you compared with what you paid to acquire them?

At $1M ARR this is the number that decides whether $1.5M buys growth or just replaces churn. Everything else in the deck is good enough already.

If there is time

Channel risk

A lot of your growth comes from search terms like “AI humanizer”. What happens to that channel if universities or the search engines decide those tools are cheating?

The big model

OpenAI ships study modes and citations for free. Which part of your product is hard for them to copy — and is it the product or the distribution?

MemStera

Photonic memory · Netherlands · Proof of concept

Memory that is written with light instead of electricity. AI chips spend most of their time waiting for data to arrive from memory; MemStera wants to remove that wait using all-optical magnetisation switching — ultrafast laser pulses that flip magnetic bits directly, with the data staying put when the power is off. The claim is sub-nanosecond access, “hundreds of times faster” than conventional memory, aimed at AI training and high-performance computing.

The physics is real and published academically — the company says it builds on decades of research. What is not stated anywhere public: the development stage, any measured device result, the fab or research partners by name, the funding raised, or the team beyond the founder. The website is three paragraphs long. memstera.com, retrieved 21 Sep 2026 · deck is behind a DocSend email gate

Lead with this

What exists

Help a non-physicist place this on the ladder. Today, is this a simulation, a single working cell in a university lab, or a chip somebody can plug in — and what was the last thing you measured with your own hands?

This is the whole question for a hardware company at this stage. The distance between “a physics result exists” and “a device exists” is usually ten years and a hundred million dollars.

If there is time

Who must say yes

For this to matter, someone big has to adopt it — a chipmaker, a memory maker or a cloud. Which one, and what is your way into that decision?

Cost of the journey

How much money and how many years to the first product a customer can buy, and what is the next milestone that would convince a generalist investor you are on track?

nBlick

AI search visibility · France · PMF claimed

SEO for the age when customers ask ChatGPT instead of Google. nBlick builds buyer personas, fires thousands of simulated questions at the main AI assistants, and reports how often your brand is mentioned, in what tone, and against which competitors — then recommends what to change. Buyers are marketing and growth teams; there is a separate plan for agencies managing several clients.

Twelve-plus customer logos are shown (Anchorage Digital, Certideal, Macrocosmos, Brighthire, GuruWalk and others), which is real for a company this young. No revenue, user count or price is published — you must create an account to see pricing. The category is crowded and well funded: their own comparison pages name Profound, Peec AI, Otterly and Semrush. nblick.com (redirect from trynblick.com), retrieved 21 Sep 2026

Lead with this

Proof of effect

Measuring where a brand appears in AI answers is becoming easy — several funded companies and Semrush now do it. Can you show one customer where your recommendations actually changed how the assistants talk about them, and can you repeat that on demand?

Monitoring is a dashboard and churns. Changing the outcome is a service people renew for. The answer tells you which business you are looking at.

If there is time

Revenue shape

Of those twelve logos, how many pay monthly, and what does an average customer pay a year?

Staying alive

If one of the big SEO platforms gives this away inside a plan customers already buy, what is your answer — a niche, a channel, or something in the data they cannot copy?

Neology

Clean power · Switzerland · Revenue, pilots 2026

A replacement for the diesel generator. Ammonia is easy to transport and already has a global supply chain; Neology’s box cracks it into hydrogen on site, cleans the gas and runs a fuel cell, giving power with no CO₂ at the point of use. Two products from the same core: a standalone cracker that sells hydrogen to whoever needs it, and the full power generator for off-grid and backup use in construction, telecom, agriculture and defence.

From the deck: seed of USD 2.5M closed in December 2025, a convertible loan open now, pre-Series A planned for Q2 2027; revenue of USD 300K in 2025 and USD 750K projected for 2026; pilot programme and commercial availability from summer 2026. Unit economics claimed: 55 cents/kWh versus 81 cents/kWh for a diesel generator, and CHF 5/kg of hydrogen cracked on site versus CHF 20/kg delivered by tube trailer. Investors include the Toyota Mobility Foundation, Venture Kick and Kickfund. Working prototype demonstrated on video; team has four PhDs across catalysis, reactors and process design. Neology deck + neology.ch · read 21 Sep 2026

Lead with this

The cost claim

Your table says your power is cheaper per kWh than diesel. At what ammonia price is that true, who is selling you that ammonia today, and what does the comparison look like if you must buy green ammonia at the price it actually costs in Europe?

Everything in this business rides on one input price. A founder who answers with the price, the supplier and the sensitivity is running a real company; a founder who repeats the slide is not.

If there is time

Which product

You sell both hydrogen crackers and power generators. Which one is bringing the revenue today, and which one are you betting the company on?

Permission to use it

Ammonia is toxic and regulated. What does a construction site or a telecom operator need in order to be allowed to keep a tank of it — and who carries that risk, you or them?

PolaSight

Surgical imaging · Switzerland · Pre-CE mark

During cancer surgery the surgeon waits, with the patient open, while a lab freezes and stains a piece of tissue to say whether the edges are clean. That wait is ~30–40 minutes, needs a pathologist who is often not there, and destroys the sample. PolaSight puts the fresh tissue in a standard cassette, scans it with polarised light for 60 seconds and returns an AI map of healthy versus tumour tissue. Nothing is stained, frozen or consumed, so the sample survives for normal pathology afterwards.

The most complete commercial plan in the cohort: hardware at ~$30K against competitors at $200–400K, plus $150 per scan and $8K/year service; claimed hospital saving of $1,580 per case. Built with the University of Bern and Inselspital; 2 patents filed through the university with 6 more in preparation; 6 peer-reviewed papers; 1,711 biopsies acquired in 18 months. Accuracy shown as 97% pancreas, 98% liver, 94% lung, 91% breast — but the study sizes beside them are N=19, N=11, N=8, N=9. Status today is research use only; CE mark targeted Q4 2026. Closing CHF 500K pre-seed, then a $3M seed. PolaSight deck slides 7–16 · read 21 Sep 2026

Lead with this

Size of the evidence

The accuracy numbers on your slide are excellent, but the studies behind them have eight to nineteen cases each. What is the size and the design of the study that will actually support the CE mark — and is it funded?

You are not judging the optics, you are judging whether they know what regulators will demand. A founder with the protocol, the sites and the patient count ready is a different investment from one who quotes pilot accuracy.

If there is time

What the surgeon may do

When you get the CE mark, what is the surgeon formally allowed to do with your result — act on it, or only use it alongside the pathologist? And who is liable if it is wrong?

Who signs

Hospitals buy slowly. Inside a hospital, who signs for $150 a scan — the surgeon, the pathology lab, or procurement — and how long did that take in your first site?

Query Machines

Quantum AI · Netherlands · Research stage

AI models that run on quantum computers instead of GPUs. The argument: transformers are hitting a wall — cost grows quadratically with context, energy use is becoming impossible, and benchmark gains are flattening. Query Machines builds quantum versions of attention and transformer architectures, aiming at reasoning tasks rather than chat, and eventually a pay-per-token API where the customer never knows the hardware underneath.

Sitting inside Europe’s strongest quantum cluster — TU Delft/QuTech, YES!Delft, a joint research project with Prof. Sebastian Feld’s quantum machine learning group. They say every claim has run on real quantum hardware: IBM, IonQ, IQM, Rigetti and Quantum Inspire, at about 25 qubits today, with the roadmap needing 64, then 100, then 1000+ for the actual product. Five whitepapers, three validated proofs of concept. Both founders are described as MSc students in applied physics; raising a pre-seed, use of funds 45% R&D team, 45% compute. Query Machines deck slides 5–11 · read 21 Sep 2026

Lead with this

If hardware is late

Your product needs machines with a thousand qubits, and today you run on about twenty-five. Quantum hardware has been five years away for a decade. If that timeline slips again, what can you sell in the next two years — and to whom?

There is a good answer available to them: research contracts, algorithm licensing, work with the hardware makers. If they have no bridge revenue, the investment is a bet on somebody else’s roadmap.

If there is time

The team

You are both still finishing your master’s degrees. Who is full-time on this today, and what is the plan for the next twelve months?

Owning the IP

You say the moat is intellectual property. What is filed as patents versus published as papers — and does the university have any claim on the work done with them?

Spaceborne

Propulsion · Uzbekistan · Prototype + first contract

A rocket that leaves its energy on the ground. A large microwave beam from a ground array heats hydrogen on board, so the vehicle carries propellant but not fuel energy — on their numbers, 55% propellant instead of 90%, payload ~20% instead of 4%, single stage, reusable a thousand times, and no explosive fuel on board. The long game is launch at $40/kg for the orbital data centres that NVIDIA, Google and Starcloud are already building. The near game is much smaller: electric satellite thrusters now, anti-drone directed energy in 2028–29.

From the deck: a propulsion lab running with Turin Polytechnic in Tashkent, a $200K satellite propulsion contract signed, gyrotron access secured through Bridge12 Technologies (an MIT spin-out), an engineering partnership with Roketsan, peer-reviewed papers, and four patents to be filed. Raising $1M at $10M post-money on a SAFE, with $550K committed; the milestone that unlocks the $10M+ seed is a 700-second specific impulse hydrogen thruster demo. Advisors include a gyrotron specialist and a NASA Mars landing GNC professor. Every component is claimed to exist at TRL 8–9 — the invention is the integration. Spaceborne deck · read 21 Sep 2026

Lead with this

Near-term business

The launch story is 2032 and needs a power station’s worth of ground equipment. Everything between now and then is thrusters and defence work. Tell me about the $200K contract — who is the customer, what must you deliver, and how much more of that can you sell in the next two years?

This is the bet you can actually underwrite: a components-and-defence business that may grow into a launch company. If the near-term revenue is real, the moonshot is free optionality.

If there is time

Permission

Beaming megawatts of microwaves into the sky needs a site, a grid connection and a regulator’s blessing. Which country do you expect to say yes first, and have you started that conversation?

The next round

With $1M, what is the single result that makes a serious space investor lead your next round — and what happens if the demo gives you half the performance you expect?

Splatica

Robotics training data · London · Early revenue

Robots cannot learn from video, because video has no objects and no physics. Splatica takes a three-minute walk-through filmed on a consumer 360° camera and returns a simulation-ready copy of that room: photorealistic, with each object separated and named, collision shapes, mass and friction, exported in the format NVIDIA Isaac Sim expects. A robot can then be trained in the copy and deployed in the real room the next day.

From the deck: $120K early revenue, 2,000+ environments already scanned, official technology partner of Insta360, NVIDIA Inception member, and one proven zero-shot deployment with robotics startup Opteran. Cost claim: ~$15 per scene against $1,000–$5,000 for a professional LiDAR survey. The team has worked together for ten years across WayRay, Humanoid and Jaguar Land Rover. Business model is two-stage: digital twins pay the bills now, the scene library is the asset later. Splatica deck slides 4–11 · read 21 Sep 2026

Lead with this

Which business

Your revenue today comes from scanning buildings for digital twins, but the story is about training robots. Those are different customers with different sales cycles. Which one do you want to be in three years, and what would make you drop the other?

Service revenue funding a data asset is a respectable plan — but only if they know which one is the company. Watch whether the answer names a robotics customer who pays.

If there is time

Why buy, not film

A robotics lab can buy a camera and film its own building. Why do they come to you instead — and do you own the scenes your partners capture, or do they?

The platform above you

NVIDIA sits directly above this in the stack. If they ship the same pipeline inside Omniverse next year, are you a company or a feature?

The Lithium Company

Battery restoration · USA · Proof of concept

Batteries lose capacity mainly because usable lithium is consumed over time. This team injects a proprietary electrolyte — they call it a lithium inventory refill agent — into the cell without opening it, and claim the pack comes back to roughly its original capacity. If it works at scale it turns a replacement into a service: the pack goes back to work instead of to recycling.

Claims on the site: ~99% of original rated capacity restored, at $15 per kWh, about 4× cheaper than replacement, non-destructive, nothing disassembled. Target buyers are fleet operators and grid-storage owners. The founding team previously built HyPoint and HyWatts, with advisors from Tesla and Electric Hydrogen. What is not published: how many cells have been treated, how they behave after treatment over time, or any third-party verification. thelithium.com, retrieved 21 Sep 2026 · stage given as proof of concept

Lead with this

Verification

Bringing a worn battery back to 99% is the kind of claim that makes people either invest or walk away. How many cells have you treated, on which chemistry, how many cycles did they survive afterwards — and has anyone outside the company measured it?

An independent test lab name is the answer you want. In this field, restoring capacity has been claimed many times and has usually meant a short-lived recovery.

If there is time

Who takes the risk

If a restored pack fails in a customer’s vehicle or storage site, who is responsible — you, them, or an insurer? What does the warranty look like?

Shape of the business

Are you selling a service, a chemical, or a licence to the people who already service batteries? At $15 per kWh, what does one treatment cost you to perform?

Tortin

EdTech · Switzerland · Pilots, MVP

A single workplace for university teachers, replacing the pile of tools a professor juggles today — Moodle, Zoom, Mentimeter, Excel, Notion and ChatGPT. It runs the live class, builds the course, generates exercises and rubrics for the professor to approve, shows who is falling behind, and gives students a tutor bounded by the syllabus. Co-founded by a strategy professor at HEC Lausanne, which is why it is designed to be bought by one professor rather than by a university IT department.

Pilots at HEC Lausanne, University of Geneva, Durham, the IOC and LUMS Pakistan, with 1,000+ learners; incubated at Qatar Science and Technology Park. Claims: 122 hours per semester recovered, 8× more in-class exercises, 4–6 hours saved per assignment cycle, set up in under 30 minutes with no IT approval. GDPR and FERPA compliant, no training on faculty data, Moodle-compatible, audit trail on every AI action — the governance answer universities ask for first. tortin.com, retrieved 21 Sep 2026 · stage given as MVP

Lead with this

From one professor to a campus

Starting with the individual professor is smart — it avoids procurement. But a single professor’s budget is small and they leave. How many of your pilots are paying today, and has any of them turned into a department or university contract?

Bottom-up EdTech lives or dies on that conversion. Free pilots with a thousand students are easy; the first departmental invoice is the proof.

If there is time

The incumbent

Moodle and Canvas are everywhere and are adding AI features. What keeps a university paying you on top of the system it already owns?

The founder’s time

You are a full-time professor. How much of your week is Tortin, and at what point do you have to choose?